Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Neurodesignltd has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 5 Surgical Solution Companies in UK - 2021,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Mr. Richard Ashpole FRCS, Director.
Mr. Richard Ashpole FRCS, Director
Company
Neurodesignltd
Management
Mr. Richard Ashpole FRCS, Director
Description
Neurodesignltd is a medical design company that specialises in designing surgical instruments and surgical teaching simulators for neurosurgery. The company offers ‘Rowena’ Neurosurgical Simulator (Realistic Operative Workstation for Educating Neurosurgical Apprentices) – a complete cranial neurosurgical simulator that enables a safe practice in tandem with a wide range of neurosurgical approaches and procedures. The simulator is used for training neurosurgeons in the UK., North America, Asia, and many European countries. Along with the Rowena Neurosurgical Simulator, Neurodesign has also designed a range of other products to enhance the efficiency of neurosurgical procedures
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
